Kennedy Tweaks CDC Charter to Tighten Grip on Vaccine Advisory Panel
HHS Secretary Robert F. Kennedy Jr. has amended the CDC's vaccine advisory panel charter, granting himself broader power to appoint members with less specific expertise.

Secretary Kennedy Overhauls CDC Vaccine Panel Charter Amid Legal Standoff
WASHINGTON — In a move that signals a significant shift in federal public health governance, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has issued a revised charter for the Centers for Disease Control and Prevention’s (CDC) primary vaccine advisory body. The updated document, published Monday in the Federal Register, appears designed to grant the Secretary unilateral authority over member appointments while significantly broadening—and arguably loosening—the expertise requirements for those serving on the panel.
The overhaul follows a stinging legal defeat for Kennedy. Last month, U.S. District Judge Brian Murphy issued a temporary restraining order blocking a group of advisors Kennedy had hand-picked to lead the Advisory Committee on Immunization Practices (ACIP). The injunction came after Kennedy dismissed all 17 standing experts on the committee, replacing them with individuals who critics argue share his long-held skepticism regarding vaccine safety.
A Legal Rebuff and a New Strategy
In his ruling, Judge Murphy stated that Kennedy’s appointees failed to meet the federal mandate that advisory committees be "fairly balanced" and consist of experts within relevant fields.
"A committee of non-experts cannot be said to embody ‘fairly balanced… points of view’ within the relevant scientific community," Murphy wrote, noting that the appointees lacked the requisite depth in vaccine science and immunization practices.
The court’s decision effectively paralyzed the ACIP and temporarily reinstated previous federal vaccine recommendations, including those for COVID-19 and Hepatitis B, which Kennedy’s new panel had sought to rescind immediately upon taking office.
WASHINGTON — In a move that signals a significant shift in federal public health governance, Health and Human Services (HHS) Secretary Robert F.
Redefining "Expertise"
The new charter, which must be renewed every two years, departs from decades of precedent. Historically, the ACIP charter required members to be authorities in "immunization practices," "vaccine research," and "assessment of vaccine efficacy and safety."
The 2026 renewal omits these specific core requirements. Instead, it emphasizes "geographic balance" and a "balance of specialty areas." The list of acceptable specialties has been significantly expanded to include:
- Toxicology
- Consumer issues
- State and local health department perspectives
- "Academic" and "public health" perspectives
- An open-ended "etc."
Legal analysts suggest this vague language is a direct response to Judge Murphy’s ruling, intended to make it legally difficult to challenge future appointments based on a lack of specific vaccine expertise.
The Influence of Anti-Vaccine Advocacy
The charter changes mirror proposals recently championed by the Informed Consent Action Network (ICAN), an organization led by Kennedy ally Del Bigtree. Aaron Siri, a lawyer associated with both ICAN and Kennedy’s previous political campaigns, recently submitted a draft charter to HHS that suggested members be chosen based on any area "deemed relevant by the Secretary."
Notably, the ICAN-backed draft also called for the inclusion of at least two members with "substantial experience advocating for and/or treating those injured by vaccines."
Response from HHS
HHS spokesperson Andrew Nixon dismissed concerns that the charter changes represent a radical departure from policy. In an emailed statement, Nixon characterized the renewal as part of "routine statutory requirements" that "do not signal any broader policy shift."
However, public health advocates remain wary. The ACIP’s recommendations determine which vaccines are added to the national schedule, influencing insurance coverage and school mandates across the United States. By diluting the scientific requirements for the panel, critics argue the administration is opening the door for ideology to supersede clinical evidence.
The new charter is expected to face immediate scrutiny from medical associations and potentially further challenges in federal court.




